PROKIDNEY CORP (PROK)

KYG7S53R1049 - Common Stock

4.055  +0.26 (+6.99%)

After market: 4 -0.05 (-1.36%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
98.58M99.98M40.10MN/AN/A
Operating Expenses
150.73M151.52M153.01M55.11M27.02M
Research and Development
108.32M106.71M82.07M46.26M21.04M
Selling, General, and Administrative Expenses
42.41M44.81M70.94M8.86M5.98M
Operating Income
-150.73M-151.52M-153.01M-55.11M-27.02M
Interest Income/Expense
21.62M22.07M5.77M0.0040.00K
Income Before Taxes
-129.11M-129.45M-147.24M-55.11M-26.98M
Income Tax
4.77M6.00M900.00K40.00K-230.00K
Net Income
-35.29M-35.47M-108.03M-55.15M-26.75M
EBITDA
-146.60M-147.67M-149.97M-53.13M-26.06M
 
Per Share Data
EPS Diluted Total Ops
-0.57-0.57-1.76-0.90-0.43
Non GAAP EPS
-0.57-0.57N/AN/AN/A
 
Statistics

All data in USD

Charts